TruSeq

Publications
Sequence-based physical mapping of complex genomes by whole genome profiling.

See more publications »

Events
Find upcoming conferences or webinars.
View events »
Sequencing
Find out about our next generation sequencing technologies and platforms.
Learn more »
Literature
Learn more about TruSeq products.
View literature »



With the TruSeq reagents we immediately noticed a decrease in error rates - Courtney McCormick, PhD “With the TruSeq reagents we immediately noticed a decrease in error rates.”
Everything about cancer sequencing is about accuracy - Frank Oaks “Everything about cancer sequencing is about accuracy.”
Just as we validate against Sanger sequencing, every new next generation sequencing platform that comes to market is validated against Illumina - Tzvetana Kerelska “…every new next generation sequencing platform that comes to market is validated against Illumina.”
The benefit of accurate templates is that they enable a higher fraction of clusters that are good and pass filters…you don’t have any duplicate reads or double counting of clusters - Stephen Tanner“The benefit of accurate templates is that they enable a higher fraction of clusters that are good and pass filters…”


All comparison data were obtained from publicly available sources, and from SBL and SBS systems that were commercially available at the same time. Given the limited amount of public SBL (version4) data available, Illumina referenced data from previous SBL and Genome Analyzer systems.

Compare Illumina sequencing systems